Genedata Selects Panasas Activestor

Panasas, Inc., in hybrid scale-out NAS for technical research and enterprise customers, announced that Genedata AG has chosen its ActiveStor 14 to improve the performance of its RNA/DNA sequence data analysis.

Genedata develops and markets software solutions for the statistical analysis and scientific interpretation of large biological datasets. They analyze data that requires immense throughput, such as typically found within the pharmaceutical, industrial, biotechnological and agro biotechnological worlds.

Companies within those fields use Genedata’s software systems in their R&D processes to identify causes of diseases, profile molecules for their mode of action, stratify patient populations or select the best strain for production or breeding.

“When analyzing RNA/DNA data, the typical bottleneck within the data processing pipeline is the IO bandwidth of the mapped short read from disk. A single patient sample may easily reach hundreds of gigabytes per sample and has to be passed through several times during statistical analysis,” commented Dr. Marc Flesch, product manager, Genedata. “CPU bottlenecks are typically overcome by increasing the size of the compute nodes. However, IO bandwidth shortcomings in shared-disk software designs normally remain. We overcame this issue with the scale-out NAS solution from Panasas“

“We are delighted that Gendata has chosen Panasas to satisfy its high performance storage requirements,” said Anthony Yeates, VP of EMEA sales, Panasas. “ActiveStor’s scalable hybrid architecture provides unmatched price performance for this type of application. In addition, it has proven to be very easy to maintain.“

Supplying 19 of the top 20 pharmaceutical and 5 out of the top 6 agro-biotechnological companies, Genedata’s software solution is known for its scalability and performance. Choosing ActiveStor 14 ensures they can stay ahead of the curve by exploiting its flexible capacity upgrade allowing Genedata to react to new customer projects, helping save money and time.